Nasdaq
CYTK
Cytokinetics, Incorporated
- Health Care
- Listed 2004
- 1 day
- +3.2%
- 1 month
- −4.9%
- 1 year
- +132%
$81.37 · Mkt cap $10.1B
At the 6 Aug 2026 close
Nasdaq
Cytokinetics, Incorporated
$81.37 · Mkt cap $10.1B
At the 6 Aug 2026 close
Cytokinetics, Incorporated trades under the ticker CYTK on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2004. Its market capitalisation is $10.1B. The last closing price was $81.37, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +132%, and −4.9% over the past month. Returns are price returns and exclude dividends.
This page exists because CYTK is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.